T0	Participants 49 94	patients with persistent atrial fibrillation:
T1	Participants 156 197	AF patients with effective rhythm control
T2	Participants 203 238	patients treated with rate control.
T3	Participants 270 435	266 AF patients randomized to rhythm control in the RACE study, 49 patients turned to long-term sinus rhythm and were continuously treated with oral anticoagulation.
T4	Participants 548 581	256 rate-control patients of RACE
T5	Participants 1244 1277	patients who remained on warfarin